Delivery Order SPE2DB22D1106-SPE2DB25FEFU2

Award Date 4/1/25
Potential Completion Date 4/2/25
Potential Value $34K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,061.06 firm fixed-price delivery order is for the provision of CIMZIA 2X200 MG/ML syringe kits, with a completion date of January 27, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,247.84 firm fixed-price delivery order contract is for the supply of 4558234900 CIMZIA 2X200 MG/ML Syringe Kits. The award has an ultimate completion date of August 26, 2022. This delivery order contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,590.26 firm fixed-price delivery order is for the supply of CIMZIA 2X200 MG/ML syringe kits. The award is not associated with a set-aside program and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $29,941.71, is for the delivery of CIMZIA 2X200 MG/ML syringe kits. The award is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $41,256.11 firm fixed-price delivery order is for the supply of 4567645281 CIMZIA 2X200 MG/ML syringe kits. The contract has an ultimate completion date of March 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,829.40 firm-fixed-price delivery order is for 4566384651 CIMZIA 2X200 MG/ML syringe kits. The contract has an ultimate completion date of November 12, 2024 and was awarded on November 8, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of CIMZIA 2X200 MG/ML syringe kits. The $36,106.62 firm fixed price delivery order contract has a completion date of March 7, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of pharmaceutical products...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $5,347.72, is for the delivery of CIMZIA 2X200 MG/ML SYRINGE KITS, a specialty pharmaceutical product, with a performance period through December 30, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $44,921.08 firm fixed-price delivery order is for the supply of CIMZIA 2X200 MG/ML syringe kits. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical...
This contract award from the Defense Logistics Agency (DLA) is to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of CIMZIA 2X200 MG/ML syringe kits. The $26,701.11 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEFU2
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,115.18 firm fixed-price delivery order is for the supply of CIMZIA 2X200 MG/ML syringe kits, with a period of performance through April 2, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 7/1/25, 8:52 AM